Meta-analysis of prophylaxis of CMV disease in solid organ transplantation: is Ganciclovir a superior agent to Acyclovir?
Gourishankar
S
S
Division of Nephrology (S.G.), University of Alberta, Edmonton, Alberta, Canada.
Wong
W
W
Dorval
M
M
D000212:Acyclovir / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D016377:Organ Transplantation; D016032:Randomized Controlled Trials as Topic
D007166:Immunosuppressive Agents; D015774:Ganciclovir; D000212:Acyclovir